Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
StemFlo
- Development stage
- Unknown
- Lead developer
- Globe Net Wireless
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
StemFlo is a multi-ingredient dietary supplement developed and marketed by Stemtech Corporation. It is formulated with a blend of botanical extracts and enzymes, including trans-resveratrol (extracted from Japanese Knotweed root), Theracurmin (a bioavailable form of curcumin), muscadine grape skin and seed extract, blueberry extract, and proteolytic enzymes. The product is designed to support cardiovascular health and healthy blood circulation by reducing oxidative stress and breaking down excess fibrin, a protein that can impede blood flow. The manufacturer claims that by optimizing circulatory health, StemFlo facilitates the systemic movement and flow of adult stem cells throughout the body. As a nutraceutical, it is sold in capsule form and is not evaluated by the FDA for the treatment or prevention of specific medical conditions.
- Brand names
- StemFlo
- Other names
- StemFlo
02
Targets
Fibrin (Factor Ia)
Beyond the preview
Go deeper on StemFlo.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on StemFlo.